Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of use of soluble CD24 for treating immune related adverse events in cancer therapies

Methods of use of soluble CD24 for treating immune related adverse events in cancer therapies

US Patent 11547741 · Granted Jan 10, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof2025
CD80 and CD86 binding protein compositions and uses thereof2025
CD80 and CD86 binding protein compositions and uses thereof2025
Cell cryopreservation solution and method for cryopreserving cells2025
Argonaute proteins from prokaryotes and applications thereof2025
Ras inhibitors2025
Ras inhibitors2025
Facilitating controlled molecular assembly of nanoscale structures via dynamic c2025
Ras inhibitors2025
Phytase mutant2025
Preparation method of a garment with automatic opening2025
Microbial assisted phosphorous recovery under anaerobic condition2025